Given the mechanism of action of oral semaglutide [56], which includes delayed gastric emptying [24], a number of studies have assessed the impact of oral semaglutide/SNAC on exposure to other commonly administered oral drugs [71,72,73]
Importantly, most cases are classified as mild-to-moderate, and severe diarrhea requiring medication discontinuation occurs in fewer than 3% of users
Based on current approval in the United States and prescribing criteria for treatments such as Wegovy and Mounjaro, eligibility in the UK would likely be similar and include adults with: a BMI of 30 or above (obesity), or a BMI of 27 or above with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or abnormal cholesterol levels Final eligibility will depend on how the medicine is licensed in the UK
Thus, for treatment to be most successful, clinicians recommend that alcoholic patients abstain from drinking alcohol at least 6 months prior to beginning interferon therapy
Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose